Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Atashili, J AU - Poole, C AU - Ndumbe, PM AU - Adimora, AA AU - Smith, JS TI - Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies J2 - AIDS PY - 2008 VL - 22 SP - 1493 EP - 1501 UR - https://doi.org/10.1097/QAD.0b013e3283021a37 ER - TY - JOUR LB - 2. AU - Cohen, CR AU - Lingappa, JR AU - Baeten, JM AU - Ngayo, MO AU - Spiegel, CA AU - Hong, T TI - Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples J2 - PLOS Med PY - 2012 VL - 9 SP - e1001251 UR - https://doi.org/10.1371/journal.pmed.1001251 ER - TY - JOUR LB - 3. AU - Ness, RB AU - Kip, KE AU - Hillier, SL AU - Soper, DE AU - Stamm, CA AU - Sweet, RL TI - A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease J2 - Am J Epidemiol PY - 2005 VL - 162 SP - 585 EP - 590 UR - https://doi.org/10.1093/aje/kwi243 ER - TY - JOUR LB - 4. AU - Leitich, H AU - Brunbauer, M AU - Bodner-Adler, B AU - Kaider, A AU - Egarter, C AU - Husslein, P TI - Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis J2 - Am J Obstet Gynecol PY - 2003 VL - 188 SP - 752 EP - 758 UR - https://doi.org/10.1067/mob.2003.167 ER - TY - JOUR LB - 5. AU - Hay, P TI - Bacterial vaginosis [version 1; peer review: 2 approved] J2 - F1000Res PY - 2017 VL - 6 SP - 1761 UR - https://doi.org/10.12688/f1000research.11417.1 ER - TY - JOUR LB - 6. AU - Jones, A TI - Bacterial vaginosis: a review of treatment, recurrence, and disparities J2 - J Nurse Pract PY - 2019 VL - 15 SP - 420 EP - 423 UR - https://doi.org/10.1016/j.nurpra.2019.03.010 ER - TY - JOUR LB - 7. AU - Bagnall, P AU - Rizzolo, D TI - Bacterial vaginosis: a practical review J2 - JAAPA PY - 2017 VL - 30 SP - 15 EP - 21 UR - https://doi.org/10.1097/01.JAA.0000526770.60197.fa ER - TY - JOUR LB - 8. AU - Schwebke, JR TI - Bacterial vaginosis: are we coming full circle? J2 - J Infect Dis PY - 2009 VL - 200 SP - 1633 EP - 1635 UR - https://doi.org/10.1086/648093 ER - TY - JOUR LB - 9. AU - Peebles, K AU - Velloza, J AU - Balkus, JE AU - McClelland, RS AU - Barnabas, RV TI - High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis J2 - Sex Transm Dis PY - 2019 VL - 46 SP - 304 EP - 311 UR - https://doi.org/10.1097/OLQ.0000000000000972 ER - TY - GEN LB - 10. AU - British Association for Sexual Health and HIV (BASHH) TI - UK National Guideline for the Management of Bacterial Vaginosis 2012 CY - Lichfield PB - BASHH PY - 2012 ER - TY - JOUR LB - 11. AU - Workowski, KA AU - Bolan, GA TI - Sexually transmitted diseases treatment guidelines, 2015 J2 - Recomm Rep PY - 2015 VL - 64 SP - 1 EP - 137 ER - TY - JOUR LB - 12. AU - Bradshaw, CS AU - Morton, AN AU - Hocking, J AU - Garland, SM AU - Morris, MB AU - Moss, LM TI - High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence J2 - J Infect Dis PY - 2006 VL - 193 SP - 1478 EP - 1486 UR - https://doi.org/10.1086/503780 ER - TY - JOUR LB - 13. AU - Simoes, JA AU - Bahamondes, LG AU - Camargo, RP AU - Alves, VM AU - Zaneveld, LJ AU - Waller, DP TI - A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis J2 - Br J Clin Pharmacol PY - 2006 VL - 61 SP - 211 EP - 217 UR - https://doi.org/10.1111/j.1365-2125.2005.02550.x ER - TY - JOUR LB - 14. AU - Joesoef, MR AU - Schmid, GP TI - Bacterial vaginosis: review of treatment options and potential clinical indications for therapy J2 - Clin Infect Dis PY - 1995 VL - 20 IS - Suppl. 1 SP - 72 EP - 79 UR - https://doi.org/10.1093/clinids/20.supplement_1.s72 ER - TY - ELEC LB - 15. AU - Public Health England TI - Sexually Transmitted Infections (STIs): Annual Data Tables: Table 4 PY - 2018 UR - www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables M1 - 25 February 2020 ER - TY - ELEC LB - 16. AU - HM Government TI - Tackling Antimicrobial Resistance 2019–24. The UK’s Five-year National Action Plan PY - 2019 UR - https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/784894/UK_AMR_5_year_national_action_plan.pdf M1 - 5 December 2019 ER - TY - ELEC LB - 17. AU - European Commission TI - A European One Health Action Plan Against Antimicrobial Resistance (AMR) PY - 2017 UR - https://ec.europa.eu/health/amr/sites/amr/files/amr_action_plan_2017_en.pdf M1 - 5 December 2019 ER - TY - JOUR LB - 18. AU - Fiorilli, A AU - Molteni, B AU - Milani, M TI - Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial J2 - Eur J Obstet Gynecol Reprod Biol PY - 2005 VL - 120 SP - 202 EP - 205 UR - https://doi.org/10.1016/j.ejogrb.2004.10.011 ER - TY - JOUR LB - 19. AU - Boeke, AJ AU - Dekker, JH AU - van Eijk, JT AU - Kostense, PJ AU - Bezemer, PD TI - Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial J2 - Genitourin Med PY - 1993 VL - 69 SP - 388 EP - 392 UR - https://doi.org/10.1136/sti.69.5.388 ER - TY - JOUR LB - 20. AU - Holley, RL AU - Richter, HE AU - Varner, RE AU - Pair, L AU - Schwebke, JR TI - A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis J2 - Sex Transm Dis PY - 2004 VL - 31 SP - 236 EP - 238 UR - https://doi.org/10.1097/01.OLQ.0000118423.20985.E7 ER - TY - JOUR LB - 21. AU - Andersch, B AU - Forssman, L AU - Lincoln, K AU - Torstensson, P TI - Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole J2 - Gynecol Obstet Invest PY - 1986 VL - 21 SP - 19 EP - 25 UR - https://doi.org/10.1159/000298923 ER - TY - JOUR LB - 22. AU - Fredricsson, B AU - Englund, K AU - Weintraub, L AU - Olund, A AU - Nord, CE TI - Bacterial vaginosis is not a simple ecological disorder J2 - Gynecol Obstet Invest PY - 1989 VL - 28 SP - 156 EP - 160 UR - https://doi.org/10.1159/000293556 ER - TY - JOUR LB - 23. AU - Decena, DC AU - Co, JT AU - Manalastas, RM AU - Palaypayon, EP AU - Padolina, CS AU - Sison, JM TI - Metronidazole with Lactacyd vaginal gel in bacterial vaginosis J2 - J Obstet Gynaecol Res PY - 2006 VL - 32 SP - 243 EP - 251 UR - https://doi.org/10.1111/j.1447-0756.2006.00383.x ER - TY - JOUR LB - 24. AU - Lugo-Miro, VI AU - Green, M AU - Mazur, L TI - Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis J2 - JAMA PY - 1992 VL - 268 SP - 92 EP - 95 UR - https://doi.org/10.1001/jama.1992.03490010094036 ER - TY - JOUR LB - 25. AU - Armstrong-Buisseret, L AU - Brittain, C AU - David, M AU - Dean, G AU - Griffiths, F AU - Hepburn, T TI - Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis J2 - Trials PY - 2019 VL - 20 SP - 648 UR - https://doi.org/10.1186/s13063-019-3731-7 ER - TY - JOUR LB - 26. AU - Schulz, KF AU - Altman, DG AU - Moher, D AU - CONSORT Group TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials J2 - Trials PY - 2010 VL - 11 SP - 32 UR - https://doi.org/10.1186/1745-6215-11-32 ER - TY - JOUR LB - 27. AU - Brazier, J AU - Roberts, J AU - Deverill, M TI - The estimation of a preference-based measure of health from the SF-36 J2 - J Health Econ PY - 2002 VL - 21 SP - 271 EP - 292 UR - https://doi.org/10.1016/S0167-6296(01)00130-8 ER - TY - GEN LB - 28. AU - Great Britain TI - The Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994 CY - London PB - The Stationery Office PY - 1994 ER - TY - JOUR LB - 29. AU - Ison, CA AU - Hay, PE TI - Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics J2 - Sex Transm Infect PY - 2002 VL - 78 SP - 413 EP - 415 UR - https://doi.org/10.1136/sti.78.6.413 ER - TY - JOUR LB - 30. AU - Hay, PE TI - Therapy of bacterial vaginosis J2 - J Antimicrob Chemother PY - 1998 VL - 41 SP - 6 EP - 9 UR - https://doi.org/10.1093/jac/41.1.6 ER - TY - JOUR LB - 31. AU - Larsson, PG TI - Treatment of bacterial vaginosis J2 - Int J STD AIDS PY - 1992 VL - 3 SP - 239 EP - 247 UR - https://doi.org/10.1177/095646249200300402 ER - TY - JOUR LB - 32. AU - Hillier, SL AU - Lipinski, C AU - Briselden, AM AU - Eschenbach, DA TI - Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis J2 - Obstet Gynecol PY - 1993 VL - 81 SP - 963 EP - 967 ER - TY - JOUR LB - 33. AU - Sherrard, J AU - Wilson, J AU - Donders, G AU - Mendling, W AU - Jensen, JS TI - 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge J2 - Int J STD AIDS PY - 2018 VL - 29 SP - 1258 EP - 1272 UR - https://doi.org/10.1177/0956462418785451 ER - TY - JOUR LB - 34. AU - Oppong, R AU - Smith, RD AU - Little, P AU - Verheij, T AU - Butler, CC AU - Goossens, H TI - Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance J2 - Br J Gen Pract PY - 2016 VL - 66 SP - e633 EP - e639 UR - https://doi.org/10.3399/bjgp16X686533 ER - TY - GEN LB - 35. AU - National Institute for Health and Care Excellence (NICE) TI - Guide to the Methods of Technology Appraisal 2013 CY - London PB - NICE PY - 2013 UR - www.ncbi.nlm.nih.gov/books/NBK395867/ Y2 - 27 April 2020 ER - TY - JOUR LB - 36. AU - Husereau, D AU - Drummond, M AU - Petrou, S AU - Carswell, C AU - Moher, D AU - Greenberg, D TI - Consolidated Health Economic Evaluation Reporting Standards (CHEERS) – explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force J2 - Value Health PY - 2013 VL - 16 SP - 231 EP - 250 UR - https://doi.org/10.1016/j.jval.2013.02.002 ER - TY - JOUR LB - 37. AU - Petrou, S AU - Morrell, J AU - Spiby, H TI - Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context J2 - Health Qual Life Outcomes PY - 2009 VL - 7 SP - 40 UR - https://doi.org/10.1186/1477-7525-7-40 ER - TY - JOUR LB - 38. AU - Brazier, JE AU - Roberts, J TI - The estimation of a preference-based measure of health from the SF-12 J2 - Med Care PY - 2004 VL - 42 SP - 851 EP - 859 UR - https://doi.org/10.1097/01.mlr.0000135827.18610.0d ER - TY - JOUR LB - 39. AU - Manca, A AU - Hawkins, N AU - Sculpher, MJ TI - Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility J2 - Health Econ PY - 2005 VL - 14 SP - 487 EP - 496 UR - https://doi.org/10.1002/hec.944 ER - TY - JOUR LB - 40. AU - Jakobsen, JC AU - Gluud, C AU - Wetterslev, J AU - Winkel, P TI - When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts J2 - BMC Med Res Methodol PY - 2017 VL - 17 SP - 162 UR - https://doi.org/10.1186/s12874-017-0442-1 ER - TY - BOOK LB - 41. AU - Curtis, LA AU - Burns, A TI - Unit Costs of Health and Social Care 2019 CY - Canterbury PB - Personal Social Services Research Unit, University of Kent PY - 2019 UR - www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2019/ Y2 - 20 May 2020 ER - TY - ELEC LB - 42. AU - NHS TI - National Cost Collection 2019 PY - 2020 UR - www.england.nhs.uk/national-cost-collection/ M1 - 20 May 2020 ER - TY - ELEC LB - 43. AU - Joint Formulary Committee TI - British National Formulary CY - London PB - BMJ Group and Pharmaceutical Press UR - www.medicinescomplete.com M1 - 20 May 2020 ER - TY - JOUR LB - 44. AU - Campbell, MK AU - Torgerson, DJ TI - Bootstrapping: estimating confidence intervals for cost-effectiveness ratios J2 - QJM PY - 1999 VL - 92 SP - 177 EP - 182 UR - https://doi.org/10.1093/qjmed/92.3.177 ER - TY - JOUR LB - 45. AU - Glick, HA AU - Briggs, AH AU - Polsky, D TI - Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses J2 - Expert Rev PharmacoEcon Outcomes Res PY - 2001 VL - 1 SP - 25 EP - 36 UR - https://doi.org/10.1586/14737167.1.1.25 ER - TY - JOUR LB - 46. AU - Black, WC TI - The CE plane: a graphic representation of cost-effectiveness J2 - Med Decis Making PY - 1990 VL - 10 SP - 212 EP - 214 UR - https://doi.org/10.1177/0272989X9001000308 ER - TY - JOUR LB - 47. AU - Shrestha, P AU - Cooper, BS AU - Coast, J AU - Oppong, R AU - Do Thi Thuy, N AU - Phodha, T TI - Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use J2 - Antimicrob Resist Infect Control PY - 2018 VL - 7 SP - 98 UR - https://doi.org/10.1186/s13756-018-0384-3 ER - TY - JOUR LB - 48. AU - Ramsey, SD AU - Willke, RJ AU - Glick, H AU - Reed, SD AU - Augustovski, F AU - Jonsson, B TI - Cost-effectiveness analysis alongside clinical trials II – an ISPOR Good Research Practices Task Force report J2 - Value Health PY - 2015 VL - 18 SP - 161 EP - 172 UR - https://doi.org/10.1016/j.jval.2015.02.001 ER - TY - BOOK LB - 49. AU - Gray, A AU - Clarke, PM AU - Wolstenholme, JL AU - Wordsworth, S TI - Applied Methods of Cost-effectiveness Analysis in Healthcare CY - Oxford PB - Oxford University Press PY - 2010 ER - TY - JOUR LB - 50. AU - Bradshaw, CS AU - Sobel, JD TI - Current treatment of bacterial vaginosis – limitations and need for innovation J2 - J Infect Dis PY - 2016 VL - 214 IS - Suppl. 1 SP - 14 EP - 20 UR - https://doi.org/10.1093/infdis/jiw159 ER - TY - JOUR LB - 51. AU - Pollock, K AU - Wilson, E TI - Care and communication between health professionals and patients affected by severe or chronic illness in community care settings: a qualitative study of care at the end of life J2 - Health Serv Deliv Res PY - 2015 VL - 3 IS - 31 UR - https://doi.org/10.3310/hsdr03310 ER - TY - JOUR LB - 52. AU - Bradshaw, CS AU - Brotman, RM TI - Making inroads into improving treatment of bacterial vaginosis – striving for long-term cure J2 - BMC Infect Dis PY - 2015 VL - 15 SP - 292 UR - https://doi.org/10.1186/s12879-015-1027-4 ER - TY - JOUR LB - 53. AU - Hull, CE AU - McLella, AR TI - Acute and recurrent bacterial vaginosis J2 - Clin Rev PY - 2016 VL - 26 SP - 43 EP - 44 SP - 46–8 ER - TY - JOUR LB - 54. AU - Barbosa, CD AU - Balp, MM AU - Kulich, K AU - Germain, N AU - Rofail, D TI - A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence J2 - Patient Prefer Adherence PY - 2012 VL - 6 SP - 39 EP - 48 UR - https://doi.org/10.2147/PPA.S24752 ER - TY - JOUR LB - 55. AU - Sekhon, M AU - Cartwright, M AU - Francis, JJ TI - Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework J2 - BMC Health Serv Res PY - 2017 VL - 17 SP - 88 UR - https://doi.org/10.1186/s12913-017-2031-8 ER - TY - JOUR LB - 56. AU - Bilardi, JE AU - Walker, S AU - Temple-Smith, M AU - McNair, R AU - Mooney-Somers, J AU - Bellhouse, C TI - The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis J2 - PLOS ONE PY - 2013 VL - 8 SP - e74378 UR - https://doi.org/10.1371/journal.pone.0074378 ER - TY - JOUR LB - 57. AU - Anstey Watkins, J AU - Ross, JDC AU - Thandi, S AU - Brittain, C AU - Kai, J AU - Griffiths, F TI - Acceptability of and treatment preferences for recurrent bacterial vaginosis – topical lactic acid gel or oral metronidazole antibiotic: qualitative findings from the VITA trial J2 - PLOS ONE PY - 2019 VL - 14 SP - e0224964 UR - https://doi.org/10.1371/journal.pone.0224964 ER - TY - JOUR LB - 58. AU - Braun, V AU - Clarke, V TI - Using thematic analysis in psychology J2 - Qual Res Psychol PY - 2006 VL - 3 SP - 77 EP - 101 UR - https://doi.org/10.1191/1478088706qp063oa ER - TY - JOUR LB - 59. AU - Bilardi, JE AU - Walker, SM AU - Temple-Smith, MJ AU - McNair, RP AU - Mooney-Somers, J AU - Vodstrcil, LA TI - Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis J2 - PLOS ONE PY - 2017 VL - 12 SP - e0173637 UR - https://doi.org/10.1371/journal.pone.0173637 ER - TY - JOUR LB - 60. AU - Turovskiy, Y AU - Sutyak Noll, K AU - Chikindas, ML TI - The aetiology of bacterial vaginosis J2 - J Appl Microbiol PY - 2011 VL - 110 SP - 1105 EP - 1128 UR - https://doi.org/10.1111/j.1365-2672.2011.04977.x ER - TY - JOUR LB - 61. AU - Payne, SC AU - Cromer, PR AU - Stanek, MK AU - Palmer, AA TI - Evidence of African-American women’s frustrations with chronic recurrent bacterial vaginosis J2 - J Am Acad Nurse Pract PY - 2010 VL - 22 SP - 101 EP - 108 UR - https://doi.org/10.1111/j.1745-7599.2009.00474.x ER - TY - JOUR LB - 62. AU - McGowan, I AU - Gomez, K AU - Bruder, K AU - Febo, I AU - Chen, BA AU - Richardson, BA TI - Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004) J2 - AIDS PY - 2011 VL - 25 SP - 1057 EP - 1064 UR - https://doi.org/10.1097/QAD.0b013e328346bd3e ER - TY - JOUR LB - 63. AU - Pirotta, M AU - Fethers, KA AU - Bradshaw, CS TI - Bacterial vaginosis – more questions than answers J2 - Aust Fam Physician PY - 2009 VL - 38 SP - 394 EP - 397 ER - TY - ELEC LB - 64. AU - Centers for Disease and Control Prevention TI - 2015 Sexually Transmitted Diseases Treatment Guidelines. Bacterial Vaginosis PY - 2015 UR - www.cdc.gov/std/tg2015/bv.htm M1 - 6 August 2020 ER - TY - JOUR LB - 65. AU - Ling, Z AU - Liu, X AU - Chen, W AU - Luo, Y AU - Yuan, L AU - Xia, Y TI - The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics J2 - Microb Ecol PY - 2013 VL - 65 SP - 773 EP - 780 UR - https://doi.org/10.1007/s00248-012-0154-3 ER - TY - JOUR LB - 66. AU - Muzny, CA AU - Kardas, P TI - A narrative review of current challenges in the diagnosis and management of bacterial vaginosis J2 - Sex Transm Dis PY - 2020 VL - 47 SP - 441 EP - 446 UR - https://doi.org/10.1097/OLQ.0000000000001178 ER - TY - JOUR LB - 67. AU - Hay, P TI - Recurrent bacterial vaginosis J2 - Curr Opin Infect Dis PY - 2009 VL - 22 SP - 82 EP - 86 UR - https://doi.org/10.1097/QCO.0b013e32832180c6 ER - TY - JOUR LB - 68. AU - Sobel, JD AU - Kaur, N AU - Woznicki, NA AU - Boikov, D AU - Aguin, T AU - Gill, G AU - Akins, RA TI - Prognostic indicators of recurrence of bacterial vaginosis J2 - J Clin Microbiol PY - 2019 VL - 57 SP - e00227 EP - e00219 UR - https://doi.org/10.1128/JCM.00227-19 ER - TY - JOUR LB - 69. AU - Verstraelen, H AU - Swidsinski, A TI - The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment: 2018 update J2 - Curr Opin Infect Dis PY - 2019 VL - 32 SP - 38 EP - 42 UR - https://doi.org/10.1097/QCO.0000000000000516 ER - TY - JOUR LB - 70. AU - Norris Turner, A AU - Carr Reese, P AU - Snead, MC AU - Fields, K AU - Ervin, M AU - Kourtis, AP TI - Recent biomarker-confirmed unprotected vaginal sex, but not self-reported unprotected sex, is associated with recurrent bacterial vaginosis J2 - Sex Transm Dis PY - 2016 VL - 43 SP - 172 EP - 176 UR - https://doi.org/10.1097/olq.0000000000000414 ER - TY - ELEC LB - 71. AU - Sanofi TI - Metronodazole Summary of Product Characteristics PY - 2019 UR - www.medicines.org.uk/emc/product/9238/smpc#UNDESIRABLE_EFFECTS M1 - 4 May 2020 ER - TY - JOUR LB - 72. AU - Sobel, JD AU - Ferris, D AU - Schwebke, J AU - Nyirjesy, P AU - Wiesenfeld, HC AU - Peipert, J TI - Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis J2 - Am J Obstet Gynecol PY - 2006 VL - 194 SP - 1283 EP - 1289 UR - https://doi.org/10.1016/j.ajog.2005.11.041 ER - TY - JOUR LB - 73. AU - Beigi, RH AU - Austin, MN AU - Meyn, LA AU - Krohn, MA AU - Hillier, SL TI - Antimicrobial resistance associated with the treatment of bacterial vaginosis J2 - Am J Obstet Gynecol PY - 2004 VL - 191 SP - 1124 EP - 1129 UR - https://doi.org/10.1016/j.ajog.2004.05.033 ER - TY - JOUR LB - 74. AU - Schuyler, JA AU - Mordechai, E AU - Adelson, ME AU - Sobel, JD AU - Gygax, SE AU - Hilbert, DW TI - Identification of intrinsically metronidazole-resistant clades ofGardnerella vaginalis J2 - Diagn Microbiol Infect Dis PY - 2016 VL - 84 SP - 1 EP - 3 UR - https://doi.org/10.1016/j.diagmicrobio.2015.10.006 ER - TY - JOUR LB - 75. AU - Deng, ZL AU - Gottschick, C AU - Bhuju, S AU - Masur, C AU - Abels, C AU - Wagner-Döbler, I TI - Metatranscriptome analysis of the vaginal microbiota reveals potential mechanisms for protection against metronidazole in bacterial vaginosis J2 - mSphere PY - 2018 VL - 3 SP - e00262 EP - e00218 UR - https://doi.org/10.1128/mSphereDirect.00262-18 ER - TY - JOUR LB - 76. AU - Bradshaw, CS AU - Tabrizi, SN AU - Fairley, CK AU - Morton, AN AU - Rudland, E AU - Garland, SM TI - The association ofAtopobium vaginaeandGardnerella vaginaliswith bacterial vaginosis and recurrence after oral metronidazole therapy J2 - J Infect Dis PY - 2006 VL - 194 SP - 828 EP - 836 UR - https://doi.org/10.1086/506621 ER - TY - JOUR LB - 77. AU - Balkus, JE AU - Srinivasan, S AU - Anzala, O AU - Kimani, J AU - Andac, C AU - Schwebke, J TI - Impact of periodic presumptive treatment for bacterial vaginosis on the vaginal microbiome among women participating in the preventing vaginal infections trial J2 - J Infect Dis PY - 2017 VL - 215 SP - 723 EP - 731 UR - https://doi.org/10.1093/infdis/jiw622 ER - TY - JOUR LB - 78. AU - Elliott, TS AU - Stone, JW TI - Review article: metronidazole and the anaerobic gut flora J2 - Aliment Pharmacol Ther PY - 1990 VL - 4 SP - 227 EP - 238 UR - https://doi.org/10.1111/j.1365-2036.1990.tb00467.x ER - TY - JOUR LB - 79. AU - Tedesco, FJ TI - Clindamycin and colitis: a review J2 - J Infect Dis PY - 1977 VL - 135 SP - S95 EP - S98 UR - https://doi.org/10.1093/infdis/135.supplement.s95 ER - TY - JOUR LB - 80. AU - Meadowcroft, AM AU - Diaz, PR AU - Latham, GS TI - Clostridium difficiletoxin-induced colitis after use of clindamycin phosphate vaginal cream J2 - Ann Pharmacother PY - 1998 VL - 32 SP - 309 EP - 311 UR - https://doi.org/10.1345/aph.17251 ER - TY - JOUR LB - 81. AU - Sobel, JD AU - Kaur, N AU - Woznicki, NA AU - Boikov, D AU - Aguin, T AU - Gill, G AU - Akins, RA TI - Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses J2 - Infect Drug Resist PY - 2019 VL - 12 SP - 2297 EP - 2307 UR - https://doi.org/10.2147/IDR.S213853 ER - TY - JOUR LB - 82. AU - Bradshaw, CS AU - Pirotta, M AU - De Guingand, D AU - Hocking, JS AU - Morton, AN AU - Garland, SM TI - Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial J2 - PLOS ONE PY - 2012 VL - 7 SP - e34540 UR - https://doi.org/10.1371/journal.pone.0034540 ER - TY - JOUR LB - 83. AU - Broumas, AG AU - Basara, LA TI - Potential patient preference for 3-day treatment of bacterial vaginosis: responses to new suppository form of clindamycin J2 - Adv Ther PY - 2000 VL - 17 SP - 159 EP - 166 UR - https://doi.org/10.1007/BF02853158 ER - TY - JOUR LB - 84. AU - Marrazzo, JM AU - Dombrowski, JC AU - Wierzbicki, MR AU - Perlowski, C AU - Pontius, A AU - Dithmer, D AU - Schwebke, J TI - Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: a randomized, single-blind, phase 2, controlled trial J2 - Clin Infect Dis PY - 2019 VL - 68 SP - 803 EP - 809 UR - https://doi.org/10.1093/cid/ciy554 ER - TY - JOUR LB - 85. AU - van de Wijgert, J AU - Verwijs, MC TI - Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs J2 - BJOG PY - 2020 VL - 127 SP - 287 EP - 299 UR - https://doi.org/10.1111/1471-0528.15870 ER - TY - JOUR LB - 86. AU - Cohen, CR AU - Wierzbicki, MR AU - French, AL AU - Morris, S AU - Newmann, S AU - Reno, H TI - Randomized trial of lactin-v to prevent recurrence of bacterial vaginosis J2 - N Engl J Med PY - 2020 VL - 382 SP - 1906 EP - 1915 UR - https://doi.org/10.1056/NEJMoa1915254 ER - TY - JOUR LB - 87. AU - Balkus, JE AU - Carter, KA AU - McClelland, RS TI - Lessons from suppressive therapy and periodic presumptive treatment for bacterial vaginosis J2 - Curr Infect Dis Rep PY - 2019 VL - 21 SP - 34 UR - https://doi.org/10.1007/s11908-019-0688-3 ER - TY - JOUR LB - 88. AU - Aldunate, M AU - Srbinovski, D AU - Hearps, AC AU - Latham, CF AU - Ramsland, PA AU - Gugasyan, R TI - Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis J2 - Front Physiol PY - 2015 VL - 6 SP - 164 UR - https://doi.org/10.3389/fphys.2015.00164 ER - TY - JOUR LB - 89. AU - Haggerty, CL AU - Ness, RB AU - Amortegui, A AU - Hendrix, SL AU - Hillier, SL AU - Holley, RL TI - Endometritis does not predict reproductive morbidity after pelvic inflammatory disease J2 - Am J Obstet Gynecol PY - 2003 VL - 188 SP - 141 EP - 148 UR - https://doi.org/10.1067/mob.2003.87 ER - TY - JOUR LB - 90. AU - Powell, A AU - Ghanem, KG AU - Rogers, L AU - Zinalabedini, A AU - Brotman, RM AU - Zenilman, J AU - Tuddenham, S TI - Clinicians’ use of intravaginal boric acid maintenance therapy for recurrent vulvovaginal candidiasis and bacterial vaginosis J2 - Sex Transm Dis PY - 2019 VL - 46 SP - 810 EP - 812 UR - https://doi.org/10.1097/OLQ.0000000000001063 ER - TY - JOUR LB - 91. AU - Shukla, A AU - Sobel, JD TI - Vulvovaginitis caused byCandidaspecies following antibiotic exposure J2 - Curr Infect Dis Rep PY - 2019 VL - 21 SP - 44 UR - https://doi.org/10.1007/s11908-019-0700-y ER - TY - JOUR LB - 92. AU - Bartley, JB AU - Ferris, DG AU - Allmond, LM AU - Dickman, ED AU - Dias, JK AU - Lambert, J TI - Personal digital assistants used to document compliance of bacterial vaginosis treatment J2 - Sex Transm Dis PY - 2004 VL - 31 SP - 488 EP - 491 UR - https://doi.org/10.1097/01.olq.0000135990.21755.51 ER - TY - JOUR LB - 93. AU - Schwebke, JR AU - Desmond, R TI - Natural history of asymptomatic bacterial vaginosis in a high-risk group of women J2 - Sex Transm Dis PY - 2007 VL - 34 SP - 876 EP - 877 UR - https://doi.org/10.1097/OLQ.0b013e318073bd82 ER - TY - JOUR LB - 94. AU - Keane, FE AU - Ison, CA AU - Taylor-Robinson, D TI - A longitudinal study of the vaginal flora over a menstrual cycle J2 - Int J STD AIDS PY - 1997 VL - 8 SP - 489 EP - 494 UR - https://doi.org/10.1258/0956462971920631 ER - TY - JOUR LB - 95. AU - Chawla, R AU - Bhalla, P AU - Chadha, S AU - Grover, S AU - Garg, S TI - Comparison of Hay’s criteria with Nugent’s scoring system for diagnosis of bacterial vaginosis J2 - Biomed Res Int PY - 2013 VL - 2013 SP - 365194 UR - https://doi.org/10.1155/2013/365194 ER - TY - JOUR LB - 96. AU - Forsum, U AU - Jakobsson, T AU - Larsson, PG AU - Schmidt, H AU - Beverly, A AU - Bjørnerem, A TI - An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis J2 - APMIS PY - 2002 VL - 110 SP - 811 EP - 818 UR - https://doi.org/10.1034/j.1600-0463.2002.1101107.x ER - TY - ELEC LB - 97. AU - Pharmaceutical Services Negotiating Committee TI - Services and Commissioning PY - 2020 UR - https://psnc.org.uk/services-commissioning/ M1 - 20 May 2020 ER - TY - ELEC LB - 98. AU - NHS TI - Reference Costs 2017/18 PY - 2018 UR - https://improvement.nhs.uk/resources/reference-costs/ M1 - 30 May 2020 ER -